Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2176 to 2190 of 8997 results

  1. MT658 Quit Genius for Smoking Cessation

    Topic prioritisation

  2. Topical tapinarof for treating atopic dermatitis in people 2 years and over ID6713: consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

    We are listening to your views on this Technology appraisal guidance. Comments close 1 July 2026.

  3. Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]

    Topic prioritisation

  4. Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over [TSID12254]

    Topic prioritisation

  5. Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]

    Topic prioritisation

  6. Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

    Topic prioritisation

  7. d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696)

    Topic prioritisation

  8. Lebrikizumab for treating atopic dermatitis in children [TSID12133]

    Topic prioritisation

  9. Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]

    Topic prioritisation

  10. Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]

    Topic prioritisation

  11. Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

    Topic prioritisation

  12. Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage

    Topic prioritisation

  13. Bariatric left gastric artery embolisation

    Topic prioritisation

  14. Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]

    In development Reference number: GID-TA11565 Expected publication date:  18 November 2026

  15. Budesonide orodispersible tablet for maintaining remission of eosinophilic oesophagitis in people 18 years and over [ID6486]

    Awaiting development Reference number: GID-TA11623 Expected publication date: TBC